FIELD: medical engineering.
SUBSTANCE: device has textile cotton stockinet of 110-210 g/m2 saturated with aqueous solution of polyethylene glycols having molecular weight of 200-2000 and antiseptic and anesthetic drugs. Substrate bears polyethylene glycols 10-50 mg/cm2; antiseptics 0.03-1.0 mg/cm2; anesthetics 0.05-1.2 mg/cm2. Sorption layer is produced above the treatment layer, the former being fabricated from nonwoven fabric to secure bandage sorption power at the level of 10g/g. Textile drug carrier is optionally cotton gauze of 150-250 g/m2 and mesh dimensions of at least 1.5x1.5 mm. Chlorhexidine, Furagin, Iodopironum, povidone-iodine, Quinosol, or Dioxidine are taken as the antiseptic drugs. Lidocaine, Dicaine, Anylocine, and Trimecaine are taken as the anesthetic drugs. Fabric perforation is produced as through canals which total area makes up 20-40% of the whole treatment layer area.
EFFECT: improved sorption and atraumatic features.
5 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DRESSING WITH PROLONGED CURING EFFECT | 1996 |
|
RU2101033C1 |
SUSTAINED-ACTION BANDAGE | 2010 |
|
RU2432177C1 |
BANDAGING MATERIAL WITH LONG-TERM THERAPEUTIC EFFECT | 2000 |
|
RU2169013C1 |
HEMOSTATIC BANDAGE | 2002 |
|
RU2200583C1 |
DRESSING WITH PROLONGED THERAPEUTIC EFFECT | 2000 |
|
RU2170075C1 |
MEDICAL WIPE FOR EXTERNAL USE | 2013 |
|
RU2519662C1 |
INDIVIDUAL DRESSING PACK | 2009 |
|
RU2407495C1 |
TAMPON FOR WOMEN WITH PROLONGED CURATIVE-PROPHYLACTIC ACTION | 2000 |
|
RU2178312C1 |
METHOD TO TREAT ULCEROUS DEFECTS AT DIABETIC FOOT SYNDROME | 2000 |
|
RU2178310C1 |
WOUND AND BURN CLOSURE AND HEALING DRESSING | 2012 |
|
RU2500431C1 |
Authors
Dates
2006-04-27—Published
2004-07-22—Filed